Better Plant Adds Neonmind Superfood Mushroom Coffees in the United States on Faire Wholesale Marketplace

Better Plant Adds Neonmind Superfood Mushroom Coffees in the United States on Faire Wholesale Marketplace

Vancouver, B.C. – December 10, 2021: Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FRA: YG3) (“Better Plant”) a wellness company that develops and sells plant-based products, is pleased to announce that it’s full line of NeonMind Superfood Mushroom Coffees are now available for purchase by retailers  in the United States (“U.S.”) on Faire Wholesale Marketplace, an online wholesale marketplace.

Faire currently serves over 170,000 independent retailers across North America, representing more retail locations than Marks & Spencer, Boots, Aldi, Starbucks, and Tesco combined.

“Being on Faire will showcase our coffee products  to retailers that are outside of our typical demographic”, says Amber Allen, Director of Sales for Better Plant. “We look forward to promoting NeonMind products on this platform and connecting with many diverse buyers.”

Faire provides a holistic, end-to-end platform that enables independent retailers to build, grow, and run their businesses. Leveraging the Faire platform benefits retailers with perks such as payment flexibility and security, free returns, shipping solutions and data-driven recommendations.

Better Plant owns four NeonMind mushroom coffee blends which are sold in the U.S.: two roasted blends and two instant coffee blends. From improving memory, alertness, and cognitive function to supporting the immune system, eliminating toxins and fighting mental and physical stress, NeonMind’s mushroom coffees put health and wellness at the forefront.

According to a report by MarketsandResearch.com, the global superfoods market size is expected to reach USD 272.47 billion by 2028. Mushrooms that are featured in NeonMind coffees, such as reishi and turkey tail are considered to be popular superfoods due to their healthful properties.

About Faire:

Faire is a curated wholesale marketplace connecting more than 170,000 North American retailers with thousands of emerging and established brands. Faire enables independent retailers to grow their business with the advantages of big box terms and empowers makers to seamlessly build and run their wholesale business. Faire was founded in 2017 and is powered by the idea that the future is local. Faire is backed by investors including Y Combinator, Lightspeed Venture Partners, Forerunner Ventures, Khosla Ventures, Sequoia Capital, Founders Fund, and DST Global. The company is headquartered in San Francisco, Kitchener-Waterloo, and Salt Lake City. To learn more, visit www.Faire.com.

Other News

On November 30, 2021 Better Plant completed the sale of its previously wholly-owned subsidiary, Wright & Well Inc., which held the licensing rights to a cannabis topicals brand in Oregon, U.S., to a non related party for an all cash deal of twenty thousand dollars.

On November 29, 2021 Better Plant changed the nature of its broker representation agreement with Hive Naturals (formerly known as Thank You Merci) that was announced on February 4, 2021. Hive Naturals was engaged to represent Better Plant’s wholly-owned subsidiaries Jusu Wellness and Jusu Bar in Canada and the U.S.. Going forward, Hive Naturals will concentrate its efforts solely on the existing Jusu Wellness accounts with Whole Foods Market and Healthy Planet, Canada.

“Our new relationship with Hive Naturals will allow us to continue to ensure exceptional customer service and to help organically grow sales within these key accounts”, says Amber Allen, Director of Sales for Better Plant.

Better Plant continues to engage Nationwide Natural Foods Inc. as a distributor for Jusu Bar in Canada, and is expanding distribution points for Jusu Bar and Jusu Wellness products through its own in-house sales team.

About Better Plant Sciences Inc.

Better Plant has a catalog of hundreds of product formulas and develops, commercializes, markets and sells over 50 products through the brands Jusu, NeonMind and Urban Juve. Better Plant products are sold through a network of over 150 online and brick-and-mortar retail locations including Whole Foods Market, Pharmasave, Healthy Planet and Vitasave. Better Plant has a talented team with expertise in digital design, branding, eCommerce and digital marketing and offers operational, financial, and other services to companies with emerging and fast growing businesses.

For more information on Better Plant, visit betterplantsciences.com or follow @betterplantsciences on Instagram.

Penny White, President & CEO

penny@betterplantsciences.com

1-833-515-2677

Investor Relations:

Alexandra Dumanski

invest@betterplantsciences.com

1-833-515-2677

Sales Inquiries:

Amber Allen, Director of Sales

amber@betterplantsciences.com

604-808-8118

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of COVID-19, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better Plant cautions readers not to place undue reliance on forward-looking statements provided by Better Plant, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better Plant expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee

Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee

CAPE TOWN, SA / ACCESSWIRE / November 1, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:

Medspresso™ is pleased to announce its live coffee webinar is scheduled for Friday, 12 November 2021 at 15:00 SAST. The webinar will feature a panel of coffee experts with decades’ worth of experience and expertise in everything from growing, roasting, brewing, and appraising coffee. The panel will dive into the current state of the coffee market and further discuss the art, craft, and science of the bean-to-cup journey and everything in-between. The esteemed panel includes Gerald CharlesAlessandro Morrico, and Michael Sachar, and is chaired by Jeff Robinson.

“Every day, millions of people around the world begin their day with a cup of coffee. Some chug it as vital fuel to get them through their day, and some savor it carefully as part of their morning ritual. For most, coffee is just a drink, but not for us. For us, it’s an art, a craft and a passion. Our devotion to coffee has taken us all over the world in the search for the finest beans. Join us for an exciting conversation exploring the history of coffee, the art of roasting, and a deep dive into the world of specialty coffee.” Michael Sachar explains.

The panel of experts will include award-winning, internationally renowned barista and roaster Gerald Charles from Rock ‘n Roller Coffee. Gerald has been involved in the South African coffee industry for over 18 years and his technical knowledge surrounding coffee and the intricacies of roasting the perfect bean is unparalleled.

Also joining the panel is Alessandro Morrico CEO of Morrico Import Export, a specialist coffee equipment importer, distributor, and coffee consulting company in South Africa. Alessandro holds an SCAE Diploma (Specialty Coffee Association of America and Europe) and is one of very few Q Graders in South Africa, meaning he has mastered the ins and outs of everything coffee. He is Vice Chairman of the Speciality Coffee Association of South Africa (SCASA) and has been Barista Championship Head Judge for over 10 years. He was certified for the World Barista Championship from 2009 to 2011. In short, Alessandro knows his beans.

Michael Sachar, the third panelist and CEO of M2Bio Food and Beverage, possesses an extraordinary amount of experience having worked in the USA, China, and the Middle East trading in raw and roasted coffee beans for 20 years. He has a very keen eye and taste for consumer demands and behavior. Michael will share his knowledge on the health benefits of the CBD and coffee combination, and lift the veil on how coffee enthusiasts can bring the world-class specialty coffee taste and experience into their homes.

To attend the webinar sign up here.

About Wuhan General Group, Inc./ M2Bio Sciences, Inc

Wuhan General Group, Inc. (DBA M2bio Sciences), through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.

Publicly traded company (OTC Pink: WUHN)

Website: www.m2bio.co

E-mail: info@m2bio.co

Follow us on Twitter: https://twitter.com/Medspresso

Follow us on Facebook: https://www.facebook.com/Medspresso

Follow us on YouTube: https://www.youtube.com/channel/Medspresso

Follow us on Instagram: https://www.instagram.com/medspresso.official

Forward-Looking Statements:

Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: Wuhan General Group, Inc./ M2Bio Sciences, Inc.

View source version on accesswire.com:
https://www.accesswire.com/670516/MedspressTM-Announces-Webinar-The-Art-Craft-and-Science-of-Coffee